CPT1A and ovarian cancer: However, many ovarian cancer cell lines including SKOV-3, Caov-3 and OVCAR-3 used in this study were known to lack p53 or carry mutant p53 [28], suggesting a p53-independent induction of p21 to respond to inactivation of CPT1A.